• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过去10年接受自体干细胞移植的多发性骨髓瘤患者的感染性并发症

Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.

作者信息

Park Hyunkyung, Youk Jeonghwan, Kim Hak Ro, Koh Youngil, Kwon Ji Hyun, Yoon Sung-Soo, Park Seonyang, Choe Pyoeng Gyun, Kim Nam Joong, Oh Myoung-Don, Park Wan Beom, Kim Inho

机构信息

Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehag-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Int J Hematol. 2017 Dec;106(6):801-810. doi: 10.1007/s12185-017-2313-2. Epub 2017 Aug 20.

DOI:10.1007/s12185-017-2313-2
PMID:28825207
Abstract

Infection is one of the main causes of early-treatment mortality in multiple myeloma (MM) patients during autologous stem cell transplantation (autoSCT). In the present study, we sought to determine the incidence of, and risk factors for, infection during hospital stays after autoSCT. We retrospectively evaluated 324 autoSCT events that occurred in 285 MM patients between 2006 and 2015, and reviewed the clinical characteristics of patients and history of infections. Sixty-eight infection events occurred, including bacteremia (24), other bacterial infections (7), as well as infections caused by Cytomegalovirus (17), Herpes simplex virus (12), Varicella zoster virus (3), Aspergillus (3) and Pneumocystis jiroveci (2). There was no significant difference in number of infections in the 2006-2010 and 2011-2015 periods (P = 0.194). Risk factors for bacteremia included higher beta-2 microglobulin levels at diagnosis [≥3.5 mg/L; adjusted odds ratio (aOR) 3.544 (95% CI 1.070-11.736), P = 0.038] and previous bortezomib treatment [aOR 4.270 (95% CI 1.389-13.125), P = 0.011]. In-hospital mortality occurred in 1.2% of all cases and all were infection-related. In conclusion, infection was the main cause of in-hospital mortality in patients who underwent autoSCT. Bacteremia was the most common type of microbiologically confirmed infection, and was associated with higher beta-2 microglobulin levels and previous bortezomib treatment.

摘要

感染是多发性骨髓瘤(MM)患者在自体干细胞移植(autoSCT)期间早期治疗死亡的主要原因之一。在本研究中,我们试图确定autoSCT后住院期间感染的发生率及危险因素。我们回顾性评估了2006年至2015年间285例MM患者发生的324次autoSCT事件,并审查了患者的临床特征和感染史。发生了68次感染事件,包括菌血症(24例)、其他细菌感染(7例),以及由巨细胞病毒(17例)、单纯疱疹病毒(12例)、水痘带状疱疹病毒(3例)、曲霉菌(3例)和耶氏肺孢子菌(2例)引起的感染。2006 - 2010年和2011 - 2015年期间的感染次数无显著差异(P = 0.194)。菌血症的危险因素包括诊断时较高的β2微球蛋白水平[≥3.5 mg/L;调整后的优势比(aOR)3.544(95%置信区间1.070 - 11.736),P = 0.038]和既往硼替佐米治疗[aOR 4.270(95%置信区间1.389 - 13.125),P = 0.011]。所有病例中有1.2%发生院内死亡,且均与感染相关。总之,感染是接受autoSCT患者院内死亡的主要原因。菌血症是微生物学确诊感染中最常见的类型,且与较高的β2微球蛋白水平和既往硼替佐米治疗相关。

相似文献

1
Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years.过去10年接受自体干细胞移植的多发性骨髓瘤患者的感染性并发症
Int J Hematol. 2017 Dec;106(6):801-810. doi: 10.1007/s12185-017-2313-2. Epub 2017 Aug 20.
2
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.接受基于硼替佐米方案治疗后进行自体干细胞移植的骨髓瘤患者移植后巨细胞病毒再激活的高发生率:来自罗马移植网络的一项调查
Transpl Infect Dis. 2014 Feb;16(1):158-64. doi: 10.1111/tid.12162. Epub 2013 Nov 12.
3
Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.β2微球蛋白水平可预测多发性骨髓瘤患者自体造血干细胞移植后的预后。
Transplant Proc. 2007 Nov;39(9):2893-7. doi: 10.1016/j.transproceed.2007.08.052.
4
Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.接受大剂量治疗后进行自体干细胞移植的多发性骨髓瘤患者早期死亡原因:一项基于丹麦全国多发性骨髓瘤登记处的研究。
Am J Hematol. 2017 Oct;92(10):E611-E614. doi: 10.1002/ajh.24857. Epub 2017 Aug 17.
5
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapse.多发性骨髓瘤自体移植的长期结局:新型药物对移植后复发具有显著的生存获益。
Clin Lymphoma Myeloma. 2009 Dec;9(6):436-42. doi: 10.3816/CLM.2009.n.086.
6
[The clinical features of infection in multiple myeloma undergoing autologous hematopoietic stem cell transplantation].[自体造血干细胞移植的多发性骨髓瘤感染的临床特征]
Zhonghua Nei Ke Za Zhi. 2011 Jan;50(1):44-7.
7
Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.骨骼和软组织浆细胞瘤骨髓瘤患者自体干细胞移植后的结局比较。
Eur J Haematol. 2014 Nov;93(5):414-21. doi: 10.1111/ejh.12377. Epub 2014 Jun 14.
8
[Clinical significance of abnormal protein bands in multiple myeloma treated with bortezomib-based induction regimen and autologous stem cell transplantation].[硼替佐米诱导方案联合自体干细胞移植治疗多发性骨髓瘤异常蛋白条带的临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):327-31. doi: 10.3760/cma.j.issn.0253-2727.2013.04.017.
9
Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.多发性骨髓瘤自体造血干细胞移植受者中根据静脉注射免疫球蛋白使用情况的感染发生率。
Transpl Infect Dis. 2015 Oct;17(5):679-87. doi: 10.1111/tid.12424. Epub 2015 Sep 26.
10
Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors.淋巴细胞增殖性恶性肿瘤外周血祖细胞移植后的感染:病因及潜在危险因素。
Am J Med. 1999 Feb;106(2):191-7. doi: 10.1016/s0002-9343(98)00409-4.

引用本文的文献

1
Death Caused by Disseminated Herpes Zoster in a Patient with Multiple Myeloma: A Case Report and Literature Review.多发性骨髓瘤患者因播散性带状疱疹死亡:一例报告及文献复习
Clin Cosmet Investig Dermatol. 2024 Apr 27;17:941-951. doi: 10.2147/CCID.S464039. eCollection 2024.
2
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.多发性骨髓瘤患者肺孢子菌肺炎的预后不良。
Ann Hematol. 2024 Apr;103(4):1327-1332. doi: 10.1007/s00277-023-05586-8. Epub 2023 Dec 20.
3
Machine learning-based infection prediction model for newly diagnosed multiple myeloma patients.

本文引用的文献

1
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens.预处理淋巴细胞减少、体能状态差以及早期治疗疗程是多发性骨髓瘤患者在接受基于硼替佐米方案治疗期间发生严重细菌感染的危险因素。
J Korean Med Sci. 2016 Apr;31(4):510-8. doi: 10.3346/jkms.2016.31.4.510. Epub 2016 Feb 22.
2
Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy.接受硼替佐米或沙利度胺化疗的多发性骨髓瘤患者的水痘带状疱疹病毒特异性细胞介导免疫与带状疱疹的发生
J Clin Virol. 2015 Dec;73:64-69. doi: 10.1016/j.jcv.2015.10.018. Epub 2015 Oct 24.
3
基于机器学习的新诊断多发性骨髓瘤患者感染预测模型
Front Neuroinform. 2023 Jan 13;16:1063610. doi: 10.3389/fninf.2022.1063610. eCollection 2022.
4
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.COVID-19 大流行对肿瘤血液病患者诊断和治疗的影响:讨论文件。
Rev Esp Quimioter. 2023 Feb;36(1):1-25. doi: 10.37201/req/087.2022. Epub 2022 Nov 2.
5
Impact of COVID-19 in patients with multiple myeloma based on a global data network.基于全球数据网络的 COVID-19 对多发性骨髓瘤患者的影响。
Blood Cancer J. 2021 Dec 10;11(12):198. doi: 10.1038/s41408-021-00588-z.
6
Early infection in post-autologous hematopoietic stem cell transplant patients: Princess Noorah Oncology Center experience.自体外周血造血干细胞移植后患者的早期感染:诺拉公主肿瘤中心的经验。
Saudi Med J. 2021 Aug;42(8):847-852. doi: 10.15537/smj.2021.42.8.20210236.
7
[Not Available].[无可用内容]。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):588-644. doi: 10.1007/s00103-020-03123-w.
8
Multiple Myeloma Index for Risk of Infection.感染风险的多发性骨髓瘤指数
J Cancer. 2018 Jun 4;9(12):2211-2214. doi: 10.7150/jca.24288. eCollection 2018.
9
Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma.在多发性骨髓瘤的自体干细胞移植期间,添加多西环素以预防环丙沙星引起的感染。
Support Care Cancer. 2018 Sep;26(9):3055-3061. doi: 10.1007/s00520-018-4165-6. Epub 2018 Mar 21.
Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors.住院多发性骨髓瘤患者的感染:主要特征及危险因素
Turk J Haematol. 2015 Sep;32(3):234-42. doi: 10.4274/tjh.2013.0173.
4
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.预防性左氧氟沙星对接受自体造血干细胞移植的多发性骨髓瘤中性粒细胞减少患者血流感染率和发热的影响。
Biol Blood Marrow Transplant. 2015 Oct;21(10):1808-14. doi: 10.1016/j.bbmt.2015.06.017. Epub 2015 Jul 3.
5
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.多发性骨髓瘤与感染:一项基于9253例多发性骨髓瘤患者的人群研究。
Haematologica. 2015 Jan;100(1):107-13. doi: 10.3324/haematol.2014.107714. Epub 2014 Oct 24.
6
Drug-induced modulation of T lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapy.药物诱导的T淋巴细胞调节作为多发性骨髓瘤患者在硼替佐米治疗期间易发生感染的潜在机制。
Cell Biochem Biophys. 2015 Jan;71(1):457-64. doi: 10.1007/s12013-014-0224-x.
7
Tailored immune responses: novel effector helper T cell subsets in protective immunity.定制免疫反应:保护性免疫中的新型效应辅助 T 细胞亚群。
PLoS Pathog. 2014 Feb 20;10(2):e1003905. doi: 10.1371/journal.ppat.1003905. eCollection 2014 Feb.
8
Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.儿童和青少年自体造血干细胞移植后的早期感染:圣裘德儿童研究医院的经验
Transpl Infect Dis. 2014 Feb;16(1):90-7. doi: 10.1111/tid.12165. Epub 2013 Nov 21.
9
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials.硼替佐米为基础的诱导方案治疗适合移植的多发性骨髓瘤患者:一项 III 期随机临床试验的荟萃分析。
Cancer. 2013 Dec 1;119(23):4119-28. doi: 10.1002/cncr.28325. Epub 2013 Sep 4.
10
IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation.IL-17 和 TNF-α 通过协同作用于内皮细胞激活来维持炎症期间的中性粒细胞募集。
J Immunol. 2012 Jun 15;188(12):6287-99. doi: 10.4049/jimmunol.1200385. Epub 2012 May 7.